INTRODUCTION: Mesenteric fibromatosis is a rare, locally invasive, non-metastasizing intra-abdominal fibroma with a high rate of recurrence. These tumors pose a diagnostic and therapeutic challenge due to its rarity and wide-ranging clinical presentation. CASE DESCRIPTION/METHODS: A 43-year-old man with a medical history of hypertension and no prior surgeries who presented with acutely worsening diffuse abdominal pain with associated bloating, nausea, and vomiting for 2 days. Physical exam revealed abdominal tenderness with deep palpation with the absence of peritoneal signs. MRI revealed a large liver mass with central necrosis suspicious of hepatocellular carcinoma, however, the biopsy was consistent with a hemangioma. Colonoscopy visualized a colonic mass with difficulty maneuvering the scope through the entire colon raising concern for primary versus metastatic colon cancer. Tumor markers were unremarkable. Gastrografin radiography demonstrated a high-grade obstructing annular mucosal lesion at the splenic flexure. He underwent left hemicolectomy with colostomy placement. Pathology demonstrated a spindle cell neoplasm with a fascicular architecture surrounded by abundant collagen fibers with no necrosis. Further histological staining was positive for vimentin, beta-catenin, and desmin conforming to mesenteric fibromatosis. DISCUSSION: Mesenteric fibromatosis is part of the clinical-pathologic spectrum of deep fibromatosis encompassing a group of benign fibroproliferative processes that are locally aggressive and have the capacity to infiltrate or recur, but not metastasize. Most cases manifest sporadically, however, there is a link with familial adenomatous polyposis (FAP), specifically Gardner syndrome. In addition, they can be locally aggressive showing recurrence even after excision. Mesenteric fibromatosis may be confused radiologically and histologically with a gastrointestinal stromal tumor (GIST), however immunohistochemical profile is helpful in differentiation. Mesenteric fibromatosis is typically negative for CD34 and CD117, which are almost universally positive in GISTs. This case illustrates the difficulty in diagnosing mesenteric fibromatosis, and a secondary lesion can complicate diagnosis. Mesenteric fibromatosis with intestinal involvement can be easily confused with other primary gastrointestinal tumors, especially with mesenchymal origin such as GIST. Hence, it should be considered in the differential diagnosis of mechanical intestinal obstruction as well as intra-abdominal masses.